trial

Deep Brain Stimulation in Treatment Resistant Schizophrenia

NCTId NCT02377505
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 8 (actual)
Sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Primary completion 2017-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
8 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2013-01
Primary completion
2017-02
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
On-StimulationOff-Stimulation

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauLead Sponsor
Fondo de Investigacion SanitariaCollaborator

Investigators

1
Iluminada Corripio, MD, PhDPrincipal Investigator

Sites

2 total
Sant Boi de Llobregat, SpainBarcelona, Spain

Facts & assertions

4 sourced
Enrollment
8
Phase
NA
Primary Completion Date
2017-02
Status
COMPLETED
relationships
The graph out of here
drug
On-Stimulation
drug
Off-Stimulation
drug
lead_sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
company
collaborator
Fondo de Investigacion Sanitaria
company
indication
Refractory Schizophrenia
indication
Schizophrenia, Treatment-Resistant
indication
investigator
Iluminada Corripio, MD, PhD
person